List details
Basic info
Status | Opinion Adopted |
---|---|
Submitter | Germany |
Submitter email | Chemg@baua.bund.de |
Regulatory programme |
|
ATP number and date | ATP18 - (16/02/2022), 23/11/2023 |
Link to ATP |
|
Classification
Proposed harmonised classification by the dossier submitter |
|
---|---|
Hazard classes open for commenting | Germ cell mutagenicity Carcinogenicity Specific target organ toxicity — repeated exposure |
Intention timeline
Date of intention | 2017-08-15 |
---|---|
Expected date of submission | 2018-12-31 |
Submitted for accordance check | 2019-08-29 |
Final submission date | 2019-11-14 |
Start of consultation | 2019-12-09 |
Deadline for commenting | 2020-02-07 |
Date of opinion | 2020-12-10 |
Legal deadline for opinion adoption | 2021-05-15 |
Documents
CLH report |
|
---|---|
Comments received |
|
Public consultations - received attachments |
|
RAC opinion |
|
Background document |
|
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
This version
Jan. 18, 2023
- ATP number and date: ATP18 - (16/02/2022), 23/11/2023
- Link to ATP / File Title: Official Journal
- Link to ATP / Full Path: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0692&qid=1667995782196
April 9, 2021
- Name: 1,3,5-Triazine-2,4,6-triamine → Melamine
March 27, 2021
- Name: Melamine → 1,3,5-Triazine-2,4,6-triamine
March 5, 2021
- Background document: https://echa.europa.eu/documents/10162/2d2ae641-e9f5-8120-d2d4-07efba0b5a0e
- Comments received: https://echa.europa.eu/documents/10162/669d27cc-16f7-5e3f-745d-9a27f697031a → https://echa.europa.eu/documents/10162/0b473fc9-36e3-def5-31f0-11b5230b8a29
- RAC opinion: https://echa.europa.eu/documents/10162/bfeec668-edf2-d959-3af9-861020103a4d
Jan. 19, 2021
- Date of opinion: 2020-12-10
- Status: Opinion Development → Opinion Adopted
March 16, 2020
- Comments received: https://echa.europa.eu/documents/10162/669d27cc-16f7-5e3f-745d-9a27f697031a
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/77e7b820-1035-a93c-f219-0f8c992b43ad
- Submitter email: Chemg@baua.bund.de
Jan. 24, 2020
- Status: Public Consultation → Opinion Development
Dec. 10, 2019
- CLH report: https://echa.europa.eu/documents/10162/3bdeab03-8147-b308-acd0-4ed5848340c0
- Deadline for commenting: 2020-02-07
- Final submission date: 2019-11-14
- Hazard classes open for commenting: Germ cell mutagenicity Carcinogenicity Specific target organ toxicity — repeated exposure
- Legal deadline for opinion adoption: 2021-05-15
- Status: Submitted → Public Consultation
- Start of consultation: 2019-12-09
Nov. 19, 2019
- Proposed harmonised classification by the dossier submitter: Carcinogenicity → Carc. 2, H351
- Proposed harmonised classification by the dossier submitter: STOT RE 1, H372
Sept. 3, 2019
- Status: Intention → Submitted
- Submitted for accordance check: 2019-08-29
April 4, 2019
- Regulatory programme: Other substance → Chemical registered under REACH
- Submitter email: chemg@baua.bund.de
Add the related substance to your watchlist to monitor this regulatory record.